SE9600406D0 - Novel coompounds - Google Patents

Novel coompounds

Info

Publication number
SE9600406D0
SE9600406D0 SE9600406A SE9600406A SE9600406D0 SE 9600406 D0 SE9600406 D0 SE 9600406D0 SE 9600406 A SE9600406 A SE 9600406A SE 9600406 A SE9600406 A SE 9600406A SE 9600406 D0 SE9600406 D0 SE 9600406D0
Authority
SE
Sweden
Prior art keywords
coompounds
novel
preparing
sufferer
administering
Prior art date
Application number
SE9600406A
Other languages
English (en)
Other versions
SE521084C2 (sv
SE9600406L (sv
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9600406(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en
Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en
Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SE9600406D0 publication Critical patent/SE9600406D0/sv
Publication of SE9600406L publication Critical patent/SE9600406L/sv
Publication of SE521084C2 publication Critical patent/SE521084C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
SE9600406A 1995-02-06 1996-02-05 Förfarande för framställning av paroxetin-hydroklorid- anhydrat från ett paroxetin-hydroklorid-solvat SE521084C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9502297.6A GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound
GBGB9503112.6A GB9503112D0 (en) 1995-02-17 1995-02-17 Novel compound
GBGB9509807.5A GB9509807D0 (en) 1995-05-15 1995-05-15 Novel compounds

Publications (3)

Publication Number Publication Date
SE9600406D0 true SE9600406D0 (sv) 1996-02-05
SE9600406L SE9600406L (sv) 1996-08-07
SE521084C2 SE521084C2 (sv) 2003-09-30

Family

ID=27267578

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9600406A SE521084C2 (sv) 1995-02-06 1996-02-05 Förfarande för framställning av paroxetin-hydroklorid- anhydrat från ett paroxetin-hydroklorid-solvat

Country Status (47)

Country Link
EP (3) EP1136490B1 (sv)
JP (2) JP2915338B2 (sv)
KR (1) KR100289885B1 (sv)
CN (3) CN1289496C (sv)
AR (2) AR001982A1 (sv)
AT (1) AT407528B (sv)
AU (2) AU701518C (sv)
BE (1) BE1009112A3 (sv)
BG (1) BG62967B1 (sv)
BR (1) BR9600534A (sv)
CA (4) CA2168829C (sv)
CH (3) CH689229A5 (sv)
CZ (1) CZ297171B6 (sv)
DE (3) DE69621777T2 (sv)
DK (2) DK11996A (sv)
DZ (1) DZ1989A1 (sv)
ES (1) ES2114471B1 (sv)
FI (3) FI111544B (sv)
FR (1) FR2730232B1 (sv)
GR (1) GR1002466B (sv)
HK (1) HK59397A (sv)
HU (1) HUP9600255A1 (sv)
IE (1) IE80500B1 (sv)
IL (1) IL117035A (sv)
IT (1) IT1289532B1 (sv)
LU (1) LU88711A1 (sv)
LV (1) LV11618B (sv)
MA (1) MA23802A1 (sv)
MC (1) MC2411A1 (sv)
MX (1) MX9600484A (sv)
MY (1) MY132529A (sv)
NL (1) NL1002248C2 (sv)
NO (3) NO301009B1 (sv)
NZ (1) NZ280943A (sv)
OA (1) OA10261A (sv)
PL (1) PL189247B1 (sv)
PT (1) PT101827B (sv)
RO (1) RO112426B1 (sv)
RU (1) RU2125052C1 (sv)
SE (1) SE521084C2 (sv)
SG (1) SG43787A1 (sv)
SI (2) SI21923B (sv)
SK (1) SK283608B6 (sv)
TR (1) TR199600096A2 (sv)
TW (1) TW503238B (sv)
UA (1) UA49796C2 (sv)
WO (1) WO1996024595A1 (sv)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3882224B2 (ja) 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
ES2331937T3 (es) * 1996-06-13 2010-01-20 Sumitomo Chemical Company, Limited Derivados de piperidina como intermediarios para la preparacion de paroxetina y procedimiento de preparacion de los mismos.
JP2000514653A (ja) * 1996-07-15 2000-11-07 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 立体特異的分割のためのエステラーゼのスクリーニングおよびその使用
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
US5874447A (en) 1997-06-10 1999-02-23 Synthon B. V. 4-Phenylpiperidine compounds for treating depression
EP0987256B1 (de) * 1997-08-08 2001-10-17 Aventis Pharma Deutschland GmbH Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
CN1300286A (zh) * 1998-03-16 2001-06-20 史密丝克莱恩比彻姆有限公司 帕罗西丁的晶形
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
AU2003200534B2 (en) * 1998-03-24 2004-12-02 Smithkline Beecham Plc Paroxetine compositions
JP3796351B2 (ja) 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) * 1998-06-16 1998-08-12 Smithkline Beecham Plc Method of treatment
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
PL345885A1 (en) * 1998-08-07 2002-01-14 Smithkline Beecham Plc Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826175D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826176D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
WO2000032594A1 (en) * 1998-11-30 2000-06-08 Smithkline Beecham Plc Mixed paroxetine propan-2-ol solvates
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9828767D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
CA2367402C (en) * 1999-03-12 2010-11-23 Basf Aktiengesellschaft Stable pharmaceutical dosage form for paroxetine anhydrate
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9914585D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923445D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2002022609A1 (fr) * 2000-09-14 2002-03-21 Asahi Glass Company, Limited Procede de production de sel de paroxetine sensiblement exempt de solvant organique
WO2003072104A1 (en) * 2002-02-22 2003-09-04 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
KR20080055990A (ko) * 2005-11-22 2008-06-19 테바 파마슈티컬 인더스트리즈 리미티드 시나칼셋 ＨＣｌ의 결정형 및 이의 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
KR930702000A (ko) * 1990-11-24 1993-09-08 데이빗 로버츠 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
SI9600036B (sl) 2006-12-31
EP1136490B1 (en) 2004-01-07
EP1378508A1 (en) 2004-01-07
CH689229A5 (de) 1998-12-31
PT101827A (pt) 1996-09-30
PL312646A1 (en) 1996-08-19
CN1143643A (zh) 1997-02-26
NO301009B1 (no) 1997-09-01
LV11618B (en) 1997-04-20
NZ280943A (en) 1997-01-29
CA2168829C (en) 1997-12-16
TW503238B (en) 2002-09-21
KR960031409A (ko) 1996-09-17
JPH11228571A (ja) 1999-08-24
AR036856A2 (es) 2004-10-06
FI111544B (sv) 2003-08-15
RU2125052C1 (ru) 1999-01-20
BG100333A (bg) 1996-08-30
MA23802A1 (fr) 1996-10-01
HU9600255D0 (en) 1996-03-28
MX198371B (sv) 2000-08-29
EP0808314A1 (en) 1997-11-26
MX9600484A (es) 1997-01-31
CA2168829A1 (en) 1996-08-07
SI9600036A (en) 1996-10-31
GR1002466B (el) 1996-11-06
DE69621777T2 (de) 2003-01-02
IE80500B1 (en) 1998-08-12
CH689804A5 (de) 1999-11-30
DE69631298D1 (de) 2004-02-12
CH688353A5 (de) 1997-08-15
NO20015070D0 (no) 2001-10-18
AU4786496A (en) 1996-08-27
CZ32096A3 (en) 1996-08-14
NL1002248C2 (nl) 1996-09-11
BE1009112A3 (fr) 1996-11-05
ES2114471B1 (es) 1999-08-16
ES2114471A1 (es) 1998-05-16
FR2730232A1 (fr) 1996-08-09
KR100289885B1 (ko) 2001-05-15
AU701518C (en) 2006-12-07
AT407528B (de) 2001-04-25
CN1216055C (zh) 2005-08-24
EP0808314B1 (en) 2002-06-12
HUP9600255A1 (en) 1997-03-28
ATA21096A (de) 2000-08-15
CZ297171B6 (cs) 2006-09-13
CN1289496C (zh) 2006-12-13
NO970939D0 (no) 1997-02-28
FI960519A (sv) 1996-08-07
AR001982A1 (es) 1998-01-07
DE69631298T2 (de) 2004-11-18
SK283608B6 (sk) 2003-10-07
SI21923A (sl) 2006-06-30
LU88711A1 (fr) 1996-08-23
FI960519A0 (sv) 1996-02-05
MC2411A1 (fr) 1996-12-02
NL1002248A1 (nl) 1996-08-06
CN1636993A (zh) 2005-07-13
FI20030370A (sv) 2003-03-12
IL117035A (en) 2000-02-29
AU701518B2 (en) 1999-01-28
WO1996024595A1 (en) 1996-08-15
SE521084C2 (sv) 2003-09-30
UA49796C2 (uk) 2002-10-15
IE960104A1 (en) 1996-08-07
RO112426B1 (ro) 1997-09-30
DE69621777D1 (de) 2002-07-18
LV11618A (lv) 1996-12-20
JP2915338B2 (ja) 1999-07-05
DE19603797A1 (de) 1996-08-14
PT101827B (pt) 1997-08-29
CA2211522C (en) 1999-12-07
AU4332896A (en) 1996-08-15
HK59397A (en) 1997-05-16
FR2730232B1 (fr) 1997-08-01
FI20030162A (sv) 2003-02-03
SE9600406L (sv) 1996-08-07
PL189247B1 (pl) 2005-07-29
NO20015070L (no) 1996-08-07
BG62967B1 (bg) 2000-12-29
DK200100223A (sv) 2001-02-12
DE19603797C2 (de) 1998-11-12
DK11996A (da) 1996-08-07
DZ1989A1 (fr) 2002-10-15
TR199600096A2 (tr) 1996-08-21
CA2210022A1 (en) 1996-08-07
IL117035A0 (en) 1996-09-12
ITMI960203A1 (it) 1997-08-05
ITMI960203A0 (sv) 1996-02-05
CN1090187C (zh) 2002-09-04
SK14396A3 (en) 1996-11-06
CA2210022C (en) 2005-09-13
SI21923B (sl) 2006-12-31
NO970939L (no) 1996-08-07
NO301009B3 (sv) 2003-01-06
IT1289532B1 (it) 1998-10-15
CA2210023C (en) 1999-02-09
NO311519B1 (no) 2001-12-03
EP1136490A1 (en) 2001-09-26
BR9600534A (pt) 1997-05-13
OA10261A (en) 1997-09-19
NO960472L (no) 1996-08-07
CA2211522A1 (en) 1996-08-07
MY132529A (en) 2007-10-31
CN1310180A (zh) 2001-08-29
JPH08245620A (ja) 1996-09-24
NO960472D0 (no) 1996-02-05
CA2210023A1 (en) 1996-08-07
SG43787A1 (en) 1997-11-14

Similar Documents

Publication Publication Date Title
SE9600406D0 (sv) Novel coompounds
ATE200279T1 (de) Herstellung von 3,4,4-trisubstituiertem piperidinyl-n-alkylcarboxylaten und zwischenverbindungen, verwendbar als opioid antagonisten
MX9701679A (es) Derivados de piperidina como antagonistas de la neuroquinina.
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
FI964565A0 (sv) Förfaranden för framställning av vattenfria och vattenhaltiga former av antihistaminpiperidinderivat, deras polymorfer och pseudomorfer
DK1109817T3 (da) Phosphohalogenhydriner, deres fremstilling og anvendelse
DE69613705D1 (de) Piperinderivate als neurokininantagoniste
DE69716810T2 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DE69816731D1 (de) Benzofuranon-derivate und verfahren zu ihrer herstellung
DE69431035T2 (de) 2-Phenyl-3-Azoylbenzothiophene zur Erhöhung der Thrombomodulin Expression
ATE303362T1 (de) Chalcon-derivate mit antiproliferativer aktivität
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
HK1017684A1 (en) Novel substituted 4-(1h-benzimidazol-2-yl)(1,4)diazepanes useful for the treatment of allergic diseases
DE69736180D1 (de) Behandlung von manischen erkrankungen
TR199901395T2 (xx) Yeni karboksi ikameli siklik karboksamid t�revleri.
SE9404438D0 (sv) New process

Legal Events

Date Code Title Description
CANC Patent cancelled, revoked after opposition
NUG Patent has lapsed